as 07-26-2024 4:00pm EST
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Founded: | 1997 | Country: | United States |
Employees: | N/A | City: | MOUNTAIN VIEW |
Market Cap: | 217.5M | IPO Year: | 2021 |
Target Price: | $16.17 | AVG Volume (30 days): | 160.7K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.18 | EPS Growth: | N/A |
52 Week Low/High: | $4.00 - $18.15 | Next Earning Date: | 08-13-2024 |
Revenue: | $69,073,000 | Revenue Growth: | 42.07% |
Revenue Growth (this year): | 18.34% | Revenue Growth (next year): | 17.65% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ORBIMED ADVISORS LLC | NPCE | 10% Owner | May 1 '24 | Sell | $14.02 | 15,690 | $219,973.80 | 3,419,851 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | May 1 '24 | Sell | $14.01 | 8,842 | $123,876.42 | 3,411,009 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | May 1 '24 | Sell | $14.03 | 4,674 | $65,576.22 | 3,406,335 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 24 '24 | Sell | $14.06 | 1,781 | $25,040.86 | 3,435,541 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 19 '24 | Sell | $14.02 | 18,253 | $255,907.06 | 3,483,722 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 19 '24 | Sell | $14.05 | 24,609 | $345,756.45 | 3,459,113 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 19 '24 | Sell | $14.29 | 21,791 | $311,393.39 | 3,437,322 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 16 '24 | Sell | $14.01 | 14,069 | $197,106.69 | 3,504,898 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 16 '24 | Sell | $14.15 | 300 | $4,245.00 | 3,504,598 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 16 '24 | Sell | $14.06 | 2,623 | $36,879.38 | 3,501,975 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 11 '24 | Sell | $14.49 | 461,899 | $6,692,916.51 | 3,542,068 | SEC Form 4 |
ORBIMED ADVISORS LLC | NPCE | 10% Owner | Apr 11 '24 | Sell | $14.42 | 23,101 | $333,116.42 | 3,518,967 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Feb 2 '24 | Sell | $15.07 | 14,143 | $213,122.28 | 81,208 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Feb 2 '24 | Sell | $15.17 | 3,446 | $52,278.23 | 77,762 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Jan 30 '24 | Sell | $15.10 | 11,262 | $170,004.39 | 97,937 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Jan 30 '24 | Sell | $15.08 | 1,923 | $28,989.61 | 96,014 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Jan 30 '24 | Sell | $15.04 | 663 | $9,971.06 | 95,351 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Jan 24 '24 | Sell | $15.03 | 827 | $12,425.68 | 109,200 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Jan 24 '24 | Sell | $15.00 | 1 | $15.00 | 109,199 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Dec 26 '23 | Sell | $10.00 | 102 | $1,020.00 | 123,327 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Dec 26 '23 | Sell | $10.12 | 13,300 | $134,647.87 | 110,027 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Dec 20 '23 | Sell | $10.14 | 2,730 | $27,695.30 | 123,429 | SEC Form 4 |
Morrell Martha | NPCE | Chief Medical Officer | Dec 6 '23 | Sell | $8.16 | 11,005 | $89,773.29 | 126,159 | SEC Form 4 |
KCK LTD. | NPCE | 10% Owner | Nov 29 '23 | Sell | $8.72 | 5,644 | $49,215.68 | 5,604,296 | SEC Form 4 |
KCK LTD. | NPCE | 10% Owner | Nov 29 '23 | Sell | $8.84 | 7,282 | $64,372.88 | 5,597,014 | SEC Form 4 |
NPCE Breaking Stock News: Dive into NPCE Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
MT Newswires
12 days ago
CNW Group
2 months ago
PR Newswire
2 months ago
Business Wire
2 months ago
AFP
2 months ago
Business Wire
2 months ago
The Wall Street Journal
2 months ago
The information presented on this page, "NPCE Neuropace Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.